Learn about the ISN’s work in advocacy below.
New! Bridging the Gaps – ISN’s Advocacy Newsletter
Look out for the first edition of ISN’s new quarterly newsletter in your inbox tomorrow. This new bulletin will focus on ISN’s advocacy initiatives and collaborations toward reducing the global burden of kidney diseases. The newsletter will highlight the favorable influence advocacy actions have on the kidney health agenda, the opportunities and challenges facing advocates, and...
Statement by the International Society of Nephrology on Oral Health at the WHO 148th Executive Board
Honorable chair, distinguished delegates, The International Society of Nephrology (ISN) welcomes the Director General’s report and supports its recommendations on how to achieve better oral health as part of the universal health coverage and noncommunicable disease agendas. Globally, more than 3.5 billion people suffer from oral diseases which disproportionally affect marginalized populations and those from a...
ISN Joins the Kidney Health Initiative
On January 7, 2021, the ISN became a member of the Kidney Health Initiative (KHI), a public-private partnership formed in 2012 by the American Society of Nephrology and the US Food and Drug Administration to enhance patient safety and foster innovation in the treatment of kidney diseases. KHI has more than 100 diverse and international...
Advocating for Global Kidney Health Throughout 2020: ISN Advocacy
In February, the ISN was present at the 146th Session of the Executive Board (EB) of the World Health Organization (WHO). The ISN called for recognition of the worldwide burden of kidney disease, asking for urgent measures to ensure that kidney health is fully integrated into national NCD plans. (Statement on Item 146.6; Statement...